Dipna Pharmachem (BOM:543594) DeferredTaxAndRevenue: ₹0 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:543594 Dipna Pharmachem Ltd BOM:543594
67 GF Score
Price ₹5.90
GF Value ₹8.96
Valuation Possible Value Trap
! 9 Warning Signs
View Full Analysis

What is Dipna Pharmachem DeferredTaxAndRevenue?

Dipna Pharmachem BOM:543594 -7.81% 67 DeferredTaxAndRevenue is ₹0 Mil as of Mar. 2026. GuruFocus rates BOM:543594 with a GF Score™ of 67/100 and a GF Value™ of ₹8.96 (Possible Value Trap). The stock has 9 warning signs investors should review.

Deferred Tax And Revenue represents the current portion of obligations, which is a liability that usually would have been paid but is now pas due.

Dipna Pharmachem's current deferred tax and revenue for the quarter that ended in Mar. 2026 was ₹0 Mil.

Dipna Pharmachem DeferredTaxAndRevenue Related Terms

Dipna Pharmachem DeferredTaxAndRevenue Historical Data

* Premium members only.

The historical data trend for Dipna Pharmachem's DeferredTaxAndRevenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Dipna Pharmachem DeferredTaxAndRevenue Chart

Dipna Pharmachem Annual Data
Trend Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
DeferredTaxAndRevenue
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Dipna Pharmachem Semi-Annual Data
Mar20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
DeferredTaxAndRevenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
BOM:543594
67GF Score
Dipna Pharmachem Ltd BOM:543594
DeferredTaxAndRevenue is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about DeferredTaxAndRevenue →
What does a DeferredTaxAndRevenue of ₹0 Mil mean?
Dipna Pharmachem (BOM:543594) has a DeferredTaxAndRevenue of ₹0 Mil as of Mar. 2026. Deferred tax and revenue represents the current portion of taxes and unearned revenue that are now past due. View historical data on Dipna Pharmachem.
Is Dipna Pharmachem's DeferredTaxAndRevenue too high?
Dipna Pharmachem's current DeferredTaxAndRevenue is ₹0 Mil. Overall, Dipna Pharmachem has a GF Score™ of 67/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Dipna Pharmachem's DeferredTaxAndRevenue compare to competitors?
Dipna Pharmachem's DeferredTaxAndRevenue of ₹0 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good DeferredTaxAndRevenue for a Healthcare Providers & Services company?
A good DeferredTaxAndRevenue depends on the Healthcare Providers & Services industry context. However, DeferredTaxAndRevenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high DeferredTaxAndRevenue mean?
A high DeferredTaxAndRevenue can signal that a stock is expensive relative to its fundamentals. Deferred tax and revenue represents the current portion of taxes and unearned revenue that are now past due. View historical data on Dipna Pharmachem. Dipna Pharmachem's current DeferredTaxAndRevenue is ₹0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dipna Pharmachem stock overvalued right now?
Based on GuruFocus' analysis, Dipna Pharmachem (BOM:543594) is currently considered Possible Value Trap. The stock's GF Value™ is ₹8.96, compared to a current price of ₹5.90 — trading 34.2% below its estimated fair value. The current DeferredTaxAndRevenue is ₹0 Mil. Dipna Pharmachem's overall GF Score™ is 67/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is DeferredTaxAndRevenue calculated?
DeferredTaxAndRevenue is calculated from a company's financial statements. For Dipna Pharmachem (BOM:543594), the current DeferredTaxAndRevenue is ₹0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Dipna Pharmachem (BOM:543594) Overvalued in 2026?

Based on GuruFocus' analysis, Dipna Pharmachem stock appears to be undervalued. The current stock price of ₹5.90 is trading 34.2% below its estimated GF Value™ of ₹8.96. GuruFocus considers Dipna Pharmachem to be Possible Value Trap.

Key valuation signals for BOM:543594:

  • DeferredTaxAndRevenue: ₹0 Mil
  • GF Value™: ₹8.96 vs. price of ₹5.90 (34.2% below fair value)
  • GF Score™: 67/100 with 9 warning signs

No single metric tells the full story. See the BOM:543594 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Dipna Pharmachem Business Description

Address A/211, Siddhi Vinayak Complex, Near D.A.V. School, Makarba, Ahmedabad, GJ, IND, 380055
Dipna Pharmachem Ltd is engaged in the trading and distribution of a wide range of pharmaceutical raw materials which is also known as APIs (Active Pharmaceutical Ingredients), Excipient and chemical formulation products. The company's product portfolio comprises of Hydrocortisone Acetate, Aceclofenac, Asprin, Levofloxacin, and others.
67GF Score

Get the complete analysis for BOM:543594

DeferredTaxAndRevenue is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹5.90
Price
₹8.96
GF Value